What Is Wegovy Made Of and How Does It Support Weight Loss?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy's active ingredient is semaglutide, a medication that works by activating GLP-1 receptors in the brain and gut to reduce appetite and slow stomach emptying. This mechanism has demonstrated sustained weight loss in clinical trials, with participants losing an average of 15% of their body weight over 68 weeks. PlexusDx delivers pharmaceutical-grade compounded semaglutide from licensed 503A pharmacies, offering accessible treatment across all 50 states.

The Active Ingredient: Understanding Semaglutide Chemistry

Semaglutide is a synthetic peptide—a chain of amino acids—engineered to closely resemble glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces after eating. This structural similarity allows semaglutide to bind to GLP-1 receptors throughout your nervous system and digestive tract. The medication was originally developed to treat type 2 diabetes before researchers discovered its powerful effects on weight management and satiety signals.

Unlike the natural GLP-1 hormone, which your body breaks down within minutes, semaglutide is modified to resist degradation for several days. This extended half-life—approximately 7 days—is why weekly injections maintain therapeutic levels in your bloodstream. The longer duration of action creates sustained appetite suppression and metabolic benefits compared to the body's endogenous GLP-1 production alone.

How Semaglutide Reduces Appetite and Promotes Satiety

Semaglutide activates specific brain regions that regulate hunger, particularly the hypothalamus and arcuate nucleus, which coordinate feeding behavior and energy expenditure. When you activate GLP-1 receptors in these areas, signals of fullness intensify while hunger-driving signals diminish. This neurological shift means you feel satisfied sooner during meals and experience less frequent cravings between eating occasions.

The medication also slows gastric emptying—the rate at which food moves from your stomach into the small intestine. Slower stomach emptying extends the feeling of fullness after meals, reducing the volume of food you consume without requiring conscious restriction. Additionally, semaglutide may increase energy expenditure in some individuals, further contributing to the overall caloric deficit needed for sustainable weight loss.

Clinical Evidence: Weight Loss Results with Semaglutide Treatment

The landmark STEP trials demonstrated semaglutide's effectiveness in non-diabetic individuals with obesity. In STEP 1, participants receiving weekly 2.4 mg semaglutide injections achieved an average weight loss of 10.2 kg (22.5 pounds) over 68 weeks, compared to 2.6 kg in the placebo group. Across the STEP program, approximately 70–80% of semaglutide users lost at least 5% of their baseline body weight, with many exceeding 15% weight loss.

Beyond weight loss alone, semaglutide improved cardiovascular risk markers including blood pressure, lipid levels, and inflammatory markers. Participants also reported improved quality of life, reduced emotional eating, and better control over food choices. These results support semaglutide's role not just as a weight-loss tool, but as a modifier of metabolic health and eating behavior patterns.

PlexusDx Compounded Semaglutide: Pharmaceutical-Grade Quality and Affordability

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and consistency without brand markups. Compounded semaglutide delivers identical active ingredients and mechanisms to brand-name Wegovy, but at a fraction of the cost. PlexusDx's flat monthly pricing model—starting at just $189 per month—removes dose-escalation sticker shock; your dose may increase over time, but your price remains the same.

Treatment through PlexusDx requires no insurance, no membership fees, and no prior authorizations. The service operates nationwide across all 50 states, with HSA and FSA eligibility for additional savings. After your first month of treatment, you may explore the Precision Peptide Genetic Test ($298) to identify personalized genetic variants affecting your GLP-1 pathway response, helping optimize your individual treatment plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as brand-name Wegovy?

Compounded semaglutide contains the identical active pharmaceutical ingredient and works through the same GLP-1 receptor mechanism as Wegovy. PlexusDx sources from licensed 503A compounding pharmacies meeting strict pharmaceutical standards. The primary difference is cost: compounded options are $189/mo month-to-month, or from $149/mo on the 6-month plan versus significantly higher brand-name pricing.

How long does semaglutide stay in your system?

Semaglutide has a half-life of approximately 7 days, meaning weekly injections maintain steady therapeutic levels. Peak concentrations occur 1–3 days after injection, and steady-state levels build over 4–5 weeks of consistent weekly dosing. This prolonged action distinguishes semaglutide from shorter-acting GLP-1 medications.

Can I get semaglutide without insurance through PlexusDx?

Yes. PlexusDx offers direct-to-patient semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required and no membership fees. All 50 states are served, and HSA/FSA accounts are accepted for tax-advantaged savings.

What are the most common side effects of semaglutide?

Gastrointestinal effects—nausea, vomiting, diarrhea, and constipation—occur in 30–50% of users, typically during dose escalation and decreasing over time. Headache and fatigue are also reported. Serious risks are rare but include pancreatitis and gallbladder issues; discuss personal risk factors with your healthcare provider before starting treatment.

How does the PlexusDx Precision Peptide Genetic Test help optimize treatment?

The Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights, including variants in GIPR and FTO, and MC4R genes that influence your response to GLP-1 therapy. Knowing your genetic predispositions helps PlexusDx clinicians personalize dosing and potentially recommend complementary compounds like tirzepatide for enhanced results.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.